Consolidated Statements of Comprehensive Income (Loss) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 38,465,008	$ (7,884,770)	$ 28,671,684	$ (19,932,566)
Available for sale securities - net unrealized loss	(57,860)	(486)	(57,860)	(486)
Total other comprehensive loss	(57,860)	(486)	(57,860)	(486)
Comprehensive income (loss)	38,407,148	(7,885,256)	28,613,824	(19,933,052)
Comprehensive loss attributable to noncontrolling interests	(254,001)	(50,054)	(687,498)	(116,933)
Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders	$ 38,661,149	$ (7,835,202)	$ 29,301,322	$ (19,816,119)